These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3535752)

  • 21. Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.
    Myhr KM; Riise T; Green Lilleås FE; Beiske TG; Celius EG; Edland A; Jensen D; Larsen JP; Nilsen R; Nortvedt MW; Smievoll AI; Vedeler C; Nyland HI
    Neurology; 1999 Mar; 52(5):1049-56. PubMed ID: 10102427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized placebo-controlled trial of recombinant human interferon alpha 2a in patients with AIDS. Interferon Alpha Study Group.
    J Acquir Immune Defic Syndr (1988); 1988; 1(2):111-8. PubMed ID: 2905740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of intralesional alpha 2-interferon on actinic keratoses.
    Edwards L; Levine N; Weidner M; Piepkorn M; Smiles K
    Arch Dermatol; 1986 Jul; 122(7):779-82. PubMed ID: 3524471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
    Clerico M; Faggiano F; Palace J; Rice G; Tintorè M; Durelli L
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005278. PubMed ID: 18425915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha interferon clinical trial for multiple sclerosis: design considerations.
    Alter M; Greenstein J; Camenga D; LaRue L
    Neuroepidemiology; 1987; 6(1-2):85-92. PubMed ID: 3306431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon beta for primary progressive multiple sclerosis.
    Rojas JI; Romano M; Ciapponi A; Patrucco L; Cristiano E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006643. PubMed ID: 19160292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial.
    Comi G; De Stefano N; Freedman MS; Barkhof F; Polman CH; Uitdehaag BM; Casset-Semanaz F; Hennessy B; Moraga MS; Rocak S; Stubinski B; Kappos L
    Lancet Neurol; 2012 Jan; 11(1):33-41. PubMed ID: 22146409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.
    Muss HB; Costanzi JJ; Leavitt R; Williams RD; Kempf RA; Pollard R; Ozer H; Zekan PJ; Grunberg SM; Mitchell MS
    J Clin Oncol; 1987 Feb; 5(2):286-91. PubMed ID: 3543247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis].
    Cabrera-Gómez JA; Echazábal-Santana N; Porrero-Martín P; Valenzuela-Silva C; Rodríguez CA; Fuentes-Suárez I; Pérez-Ruiz L; Ramos-Cedeño AM; Cabrera-Núñez JA;
    Rev Neurol; 2003 Aug 1-15; 37(3):214-20. PubMed ID: 12938052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study.
    Comi G; De Stefano N; Freedman MS; Barkhof F; Uitdehaag BM; de Vos M; Marhardt K; Chen L; Issard D; Kappos L
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):285-294. PubMed ID: 28039317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is new in the treatment of multiple sclerosis?
    Weinstock-Guttman B; Jacobs LD
    Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.
    Hirsch MS; Schooley RT; Cosimi AB; Russell PS; Delmonico FL; Tolkoff-Rubin NE; Herrin JT; Cantell K; Farrell ML; Rota TR; Rubin RH
    N Engl J Med; 1983 Jun; 308(25):1489-93. PubMed ID: 6304513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial.
    Perrillo RP; Regenstein FG; Peters MG; DeSchryver-Kecskemeti K; Bodicky CJ; Campbell CR; Kuhns MC
    Ann Intern Med; 1988 Jul; 109(2):95-100. PubMed ID: 3289433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal interferon in multiple sclerosis.
    Jacobs L; O'Malley J; Freeman A; Murawski J; Ekes R
    Arch Neurol; 1982 Oct; 39(10):609-15. PubMed ID: 6751302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Insight: interferon treatment in multiple sclerosis.
    Marrie RA; Rudick RA
    Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
    Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
    Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.